Early Safety Assessment - Drug Discovery and Development Based on

The drug candidate faces numerous efficacy and safety hurdles before moving forward to clinical testing. Here at the UPDDI we recognize the need for early identification of potential human toxicity and pharmacokinetic issues by creating a unique human liver microphysiological systems  platform for drug testing before implementing preclinical animal testing.

Early Drug Discovery and Development Guidelines: For Academic

Preclinical Working Group National Institutes of Health (NIH)

PDF) Molecular clinical safety intelligence: a system for bridging

PDF) Investigative safety strategies to improve success in drug

Using human genetics to improve safety assessment of therapeutics

From Bench to Clinic - The Chronology of Preclinical Studies - ITR

Early Phase Drug Development Solutions

Artificial intelligence for drug discovery: Resources, methods

The workflow of drug discovery and development. Words in red font